# Phase D10: Final Publication & Submission Readiness Checklist

**Project:** Multimodal Radiologic Breast Cancer Triage using Graph-Infused Transformers (GIT)  
**Corpus:** Breast Cancer Multimodal Imaging Dataset (BCMID)  
**Execution Phase:** Phase D10 — Final Research Integrity Audit and Submission Readiness  
**Audit Date:** October 16, 2026  
**Auditor:** Antigravity AI Research Team  
**Final Decision:** **READY FOR SUBMISSION REVIEW**

---

## 1. Submission-Readiness Criteria Matrix

| Criterion # | Audit Domain | Evaluation Requirement | Verified Evidence / Source | Status |
| :---: | :--- | :--- | :--- | :---: |
| **C-01** | **Patient-Level Split Isolation** | Zero patient overlap between training, validation, and held-out test sets. Multiple folders for repeat patients kept in the same split. | `data/splits/patient_stratified_split.json`. $\text{Train}\cap\text{Val}=\emptyset$, $\text{Train}\cap\text{Test}=\emptyset$, $\text{Val}\cap\text{Test}=\emptyset$. 4 repeat patients correctly grouped. | **PASS** |
| **C-02** | **Cohort Accounting & Reconciliation** | Strict concordance between raw folders (332), exclusions (17), eligible folders (315), and root patients (311). | `BCMID_annotations.tsv` joined with splits: Train 220 (217 roots), Val 48 (47 roots), Test 47 (47 roots). Legacy "314" arithmetic error resolved. | **PASS** |
| **C-03** | **Class Distribution Concordance** | Accurate partition counts for Class 0 (`LOW_RISK`) and Class 1 (`SUSPICIOUS_ACTIONABLE`). | Train: 184 / 36; Val: 40 / 8; Test: 40 / 7. Ephemeral assistant chat summary discrepancy (165/55; 38/10) corrected and documented. | **PASS** |
| **C-04** | **Model Architecture Provenance** | Implemented architecture accurately documented: Frozen EfficientNet-B0 (MG), Frozen ViT-B/16 (US), 2-layer GAT, 2-layer Cross-Attention Transformer. | `src/models/git.py`, `patient_multimodal_features.pt`. 2,897,922 trainable parameters. Bit-for-bit architecture concordance. | **PASS** |
| **C-05** | **Checkpoint Integrity & SHA-256 Hashes** | Model weights unperturbed and verified via cryptographically secure checksums. | C3: `9a60e5110973660b2d6ab4fd777c47e73124174678e84b8457494da757dafbc8`<br>D5: `e79338f82492e654ceab798250092c86e0e229cace83ea5d28a67a98db8c9e7b` | **PASS** |
| **C-06** | **Operating Point Integrity** | Evaluation strictly fixed at canonical unadjusted threshold $\tau = 0.50$. Zero post-hoc test threshold sweeps. | `outputs/phase_d/phase_d8_final_evaluation/test_metrics_c3.json`, `test_metrics_d5.json`. No test-driven threshold tuning permitted or performed. | **PASS** |
| **C-07** | **Locked Test Metric Verification** | All reported metrics match authoritative Phase D8 evaluation outputs to 4 decimal places. | C3: Acc 85.11%, Sens 85.71%, Spec 85.00%, F1 0.6316, AUC 0.9036.<br>D5: Acc 80.85%, Sens 85.71%, Spec 80.00%, F1 0.5714, AUC 0.8964.<br>All 14 metrics verified in `metric_consistency_audit.csv`. | **PASS** |
| **C-08** | **Paired Statistical Rigor** | Exact paired non-parametric tests executed to test statistical difference between C3 and D5. | McNemar exact two-sided test $p = 0.5000$ (non-significant). Wilcoxon signed-rank test $W = 314.0, p = 0.0074$. 45/47 patient agreement (95.74%). | **PASS** |
| **C-09** | **Historical Metric Reconciliation** | Forensic tracing of Phase 5 GIT1 and GIT2 test metrics against physical prediction files. | Historical hardcoded transcription errors in `scripts/evaluate_phase_c.py` (0.8679 vs 0.8857, 0.8429 vs 0.8321) fully audited and documented. | **PASS** |
| **C-10** | **Transparent Test-Set History** | Accurate disclosure that historical test evaluations occurred during Phase C prior to Phase D quarantine. | Clarified in Abstract, Section 5, and Section 7 of corrected manuscript. Test set quarantined throughout Phase D1–D7; unblinded once in Phase D8. | **PASS** |
| **C-11** | **Patient Privacy & De-Identification** | Complete removal of all patient codes, folder IDs, and identifying labels from publication-facing assets. | Regex audit confirmed 0 patient IDs in `corrected_manuscript/` Markdown, PDF, DOCX, HTML, and CSV. Figure 9 re-generated with de-identified labels. | **PASS** |
| **C-12** | **Scientific & Clinical Framing** | Strict boundary: Radiologic triage (`LOW_RISK` vs `SUSPICIOUS_ACTIONABLE`), not definitive pathology diagnosis. | Eradicated phrases claiming "cancers detected" or histopathologic proof. Framed as radiologic lesion triage under human supervision. | **PASS** |
| **C-13** | **Uncertainty & Sample Size Disclosure** | Prominent reporting of wide confidence intervals resulting from $N_{\text{pos}} = 7$ test cases. | Exact Clopper-Pearson 95% CI $[42.13\%, 99.64\%]$ documented in Abstract, Table 6, Discussion, and Limitations. No claims of proven superiority. | **PASS** |
| **C-14** | **Scholarly Citation Authenticity** | All references verified as real literature with valid DOIs, ISBNs, or repository identifiers. | All 22 citations in `references.md` and Section 13 verified against CrossRef/PubMed/Zenodo. In-text bracketed callouts aligned 100%. | **PASS** |
| **C-15** | **Multi-Format Document Export** | Full publication deliverables compiled in Markdown, PDF, DOCX, and HTML with embedded assets. | Compiled via Pandoc 2.12 and Microsoft Word COM Automation without modifying Markdown source. Verified high-resolution 300 DPI figures. | **PASS** |
| **C-16** | **Model & Weight Immutability** | Zero retraining, fine-tuning, weight modifications, or inference sweeps performed during audit. | Verified: No training or inference scripts executed during Phase D10. Checkpoints and original outputs preserved untouched. | **PASS** |

---

## 2. Final Audit Decision

### **STATUS: READY FOR SUBMISSION REVIEW**

**Justification:**
All 16 submission criteria have achieved **PASS** status. Material discrepancies in historical records have been forensically resolved and documented. Patient identifiers have been thoroughly eliminated from public deliverables. Clinical wording has been aligned with radiologic triage realities, and all metrics, confidence intervals, and statistical tests have been verified with 100% precision against authoritative saved artifacts.
